Which has the lower trailing P/E, ETON or NUTX?

NUTX has the lower trailing P/E: ETON trades at 142.41 and NUTX at 8.64. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ETON or NUTX?

Over the past five years, ETON grew revenue faster — ETON at a 47.98% CAGR versus NUTX at 37.66%.

Is ETON or NUTX more profitable?

NUTX runs the higher net margin — ETON at 12.02% versus NUTX at 21.25%.

How have ETON and NUTX total returns compared?

Over the past 5 years, ETON delivered 63.04% and NUTX delivered -18.99% annualized total return. Past performance doesn't predict future results.

Eton Pharmaceuticals, Inc. (ETON) vs Nutex Health, Inc. (NUTX)

A side-by-side comparison of Eton Pharmaceuticals, Inc. and Nutex Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ETON

Eton Pharmaceuticals, Inc.

$1.50B

$54.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

NUTX

Nutex Health, Inc.

$1.50B

$218.40HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ETON vs NUTX

growth of $100 · dividends reinvested · last 8y

ETON +789.9% (+31.4%/yr)NUTX -70.0% (-14.0%/yr)ETON compounded faster over this window

Log scale — wide-divergence pair

ETON NUTX

ETON vs NUTX: by the numbers

•NUTX is the larger company ($1.50B vs $1.50B market cap).
•NUTX trades at the lower trailing earnings multiple (8.64 vs 142.41 P/E), one valuation lens rather than an overall verdict.
•NUTX converts more revenue to profit (21.25% vs 12.02% net margin).
•ETON grew revenue faster over the past five years (47.98% vs 37.66% CAGR).

Metrics side by side

Valuation

Metric	ETON	NUTX
P/E ratio	142.41	8.64
Forward P/E	50.36	7.86
P/S ratio	14.21	1.77
P/B ratio	32.21	3.81
EV / EBITDA	72.05	4.27
FCF yield	0.98%	18.24%

Profitability

Metric	ETON	NUTX
Gross margin	57.87%	51.26%
Operating margin	0.09%	31.49%
Net margin	12.02%	21.25%
ROE	27.24%	45.63%
ROIC	20.41%	33.76%

Growth (annualized)

Metric	ETON	NUTX
Revenue CAGR (5Y)	47.98%	37.66%
EPS CAGR (5Y)	N/A	-14.73%
Total return CAGR (5Y)	63.04%	-18.99%

Frequently asked

Which has the lower trailing P/E, ETON or NUTX?: NUTX has the lower trailing P/E: ETON trades at 142.41 and NUTX at 8.64. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ETON or NUTX?: Over the past five years, ETON grew revenue faster — ETON at a 47.98% CAGR versus NUTX at 37.66%.
Is ETON or NUTX more profitable?: NUTX runs the higher net margin — ETON at 12.02% versus NUTX at 21.25%.
How have ETON and NUTX total returns compared?: Over the past 5 years, ETON delivered 63.04% and NUTX delivered -18.99% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ETON analysis Full NUTX analysis Interactive comparison tool

Dig into the metrics

Eton Pharmaceuticals P/E ratio Nutex Health P/E ratio Eton Pharmaceuticals ROE Nutex Health ROE Eton Pharmaceuticals operating margin Nutex Health operating margin Eton Pharmaceuticals revenue growth Nutex Health revenue growth Eton Pharmaceuticals free cash flow Nutex Health free cash flow

Eton Pharmaceuticals & Nutex Health appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.